Special Considerations Related To Prescribing For Children And Adolescents essay paper

/in /by

Special Considerations Related To Prescribing For Children And Adolescents

ORDER A PLAGIARISM FREE PAPER NOW

Don't use plagiarized sources. Get Your Custom Essay on
Special Considerations Related To Prescribing For Children And Adolescents essay paper
Just from $15/Page
Order Essay

Special Considerations Related to Prescribing for Children and Adolescents

Psychotropic drugs are commonly used for children and adolescents to treat mental health disorders, yet many of these drugs are not FDA approved for use in these populations. Thus, their use is considered “off-label,” and it is often up to the best judgment of the prescribing clinician. As a PMHNP, you will need to apply the best available information and research on pharmacological treatments for children in order to safely and effectively treat child and adolescent patients. What psychotherapeutic approach might be indicated as an initial treatment? What are the potential side effects of a particular drug? Special Considerations Related To Prescribing For Children And Adolescents

For this Assignment, you consider these questions and others as you explore FDA-approved (“on label”) pharmacological treatments, non-FDA-approved (“off-label”) pharmacological treatments, and nonpharmacological treatments for disorders in children and adolescents.

Special Considerations Related To Prescribing For Children And Adolescents

To Prepare

· Research Disruptive Mood Dysregulation Disorder in children and adolescents

for this Assignment.

· Use the Walden library to research evidence-based treatments for your assigned disorder in children and adolescents. You will need to recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating this disorder in children and adolescents.Special Considerations Related To Prescribing For Children And Adolescents

The Assignment (3 pages)

· Recommend one FDA-approved drug, one off-label drug, and one nonpharmacological intervention for treating -Disruptive Mood Dysregulation Disorder in children and adolescents.Special Considerations Related To Prescribing For Children And Adolescents

· Explain the risk assessment you would use to inform your treatment decision making. What are the risks and benefits of the FDA-approved medicine? What are the risks and benefits of the off-label drug?Special Considerations Related To Prescribing For Children And Adolescents

· Explain whether clinical practice guidelines exist for this disorder and, if so, use them to justify your recommendations. If not, explain what information you would need to take into consideration.

· Support your reasoning with at least three scholarly resources, one each on the FDA-approved drug, the off-label, and a non-medication intervention for the disorder. Attach the PDFs of your sources.Special Considerations Related To Prescribing For Children And Adolescents